{
    "Trade/Device Name(s)": [
        "ImmunoCAP Specific IgE",
        "ImmunoCAP Total IgE"
    ],
    "Submitter Information": "Phadia AB",
    "510(k) Number": "K161889",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051218",
        "K133404"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHB",
        "DGC"
    ],
    "Summary Letter Date": "July 8, 2016",
    "Summary Letter Received Date": "July 11, 2016",
    "Submission Date": "July 7, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.5750",
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Radioallergosorbent (RAST) immunological test system"
    ],
    "Analyte Class(es)": [
        "allergy",
        "immunology"
    ],
    "Analyte(s)": [
        "Allergen specific IgE",
        "Total IgE"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Na-Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Phadia 100",
        "Phadia 250",
        "Phadia 1000",
        "Phadia 2500",
        "Phadia 5000"
    ],
    "Method(s)/Technology(ies)": [
        "Automated quantitative immunoassay",
        "Fluorescence enzyme immunoassay"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for ImmunoCAP Specific IgE and Total IgE automated immunoassays with updated reference material for measurement of allergen specific and total IgE.",
    "Indications for Use Summary": "In vitro quantitative assays for measuring allergen specific and total IgE in human serum or plasma as aids in clinical diagnosis of IgE mediated allergic disorders, to be used with Phadia instruments in clinical laboratories.",
    "fda_folder": "Immunology"
}